A larger percentage of patients in PFA group had treatment success at 12 months compared with those receiving antiarrhythmic-drug therapy.

BOSTON -- For persistent atrial fibrillation (Afib), adding artificial intelligence guidance for ablation site selection improved success, the TAILORED trial showed. Freedom from Afib after one ...

CellFX marks another route for Afib ablation technology ...

A major clinical trial has found Boston Scientific’s Farapulse pulsed-field ablation nearly doubles the success rate of treating persistent atrial fibrillation compared with medication. One year after ...

Radiofrequency-based ablation for atrial fibrillation appears more effective than previously shown in clinical trials. Using real-world data, a new study found that the procedure eliminated atrial ...

A novel pulsed field ablation technology was safe and prevented atrial arrhythmia recurrence in most patients with paroxysmal ...

Johnson & Johnson Medtech’s Biosense Webster division presented the final results from a yearlong study of its upcoming Varipulse pulsed field ablation system, showing that more than three-quarters of ...

This content is sponsored by MedStar Washington Hospital Center. Atrial fibrillation, or AFib, is the most common type of arrhythmia (an abnormal or irregular heartbeat caused by a disturbance in the ...

Dealing with both type 2 diabetes and atrial fibrillation made it twice as difficult for Matt Jewell to live a healthy lifestyle. Medicine to control his abnormal heart rhythm slowed down his heart ...

Mark Gurarie is a writer covering health topics, technology, music, books, and culture. He also teaches health science and research writing at George Washington University's School of Medical and ...

The AVANT GUARD trial found that first-line pulsed field ablation (PFA) reduced atrial arrhythmia recurrence more than antiarrhythmic drugs in persistent atrial fibrillation. At 12 months, 56% of PFA ...